# SPSIPB vs SAPB for Thoracoscopic Surgery

> **NCT06546839** · NA · COMPLETED · sponsor: **Medipol University** · enrollment: 50 (actual)

## Conditions studied

- Lung Diseases
- Lung Cancer
- Lung Neoplasms
- Lung Cancer Metastatic
- Thoracic Diseases
- Thoracic Cancer
- Thoracic Neoplasms

## Interventions

- **DRUG:** SPSIPB blcok
- **DRUG:** SAPB block
- **DRUG:** Postoperative analgesia management

## Key facts

- **NCT ID:** NCT06546839
- **Lead sponsor:** Medipol University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-10
- **Primary completion:** 2025-06-20
- **Final completion:** 2025-06-25
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06546839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06546839, "SPSIPB vs SAPB for Thoracoscopic Surgery". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT06546839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*